Intellia Therapeutics Inc (NTLA) — Long-term Investment Intensity
Intellia Therapeutics Inc (NTLA) has a Long-term Investment Intensity of 22.7% as of December 2025. Long-term investments of $190.79 Million represent 22.7% of total assets of $842.13 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Intellia Therapeutics Inc liquid asset ratio to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Intellia Therapeutics Inc Long-term Investment Intensity (2019–2025)
This chart shows how Intellia Therapeutics Inc's Long-term Investment Intensity has evolved across 7 annual periods from 2019 to 2025. As of December 2025, the intensity stands at 22.7%, reflecting long-term investments of $190.79 Million against total assets of $842.13 Million USD. For the complete balance sheet picture, see NTLA current and non-current assets.
Annual Long-term Investment Intensity for Intellia Therapeutics Inc (2019–2025)
The table below presents the year-by-year Long-term Investment Intensity for Intellia Therapeutics Inc from 2019 to 2025, covering 7 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read NTLA total liabilities for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 22.7% | $190.79 Million | $842.13 Million | ▼ -2.9 pp |
| 2024 | 25.6% | $304.48 Million | $1.19 Billion | ▲ +13.7 pp |
| 2023 | 11.9% | $154.51 Million | $1.30 Billion | ▲ +2.5 pp |
| 2022 | 9.4% | $142.32 Million | $1.52 Billion | ▼ -23.5 pp |
| 2021 | 32.8% | $425.05 Million | $1.29 Billion | ▲ +32.1 pp |
| 2020 | 0.7% | $4.75 Million | $676.32 Million | ▼ -0.7 pp |
| 2019 | 1.4% | $4.75 Million | $334.28 Million | — |